

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.64956540 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.32987921 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.77287752 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.75304646 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.75304646 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.75304646 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.75304646 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.75304646 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.75304646 |
| 10 | response to peptidoglycan (GO:0032494) | 5.69306802 |
| 11 | respiratory burst (GO:0045730) | 5.39771941 |
| 12 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.93731814 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.92013827 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.76978183 |
| 15 | superoxide anion generation (GO:0042554) | 4.76930051 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.73639107 |
| 17 | neutrophil activation (GO:0042119) | 4.70083747 |
| 18 | granulocyte activation (GO:0036230) | 4.68366978 |
| 19 | reactive oxygen species biosynthetic process (GO:1903409) | 4.65612685 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.59022298 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 4.59022298 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 4.56859601 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.37967079 |
| 24 | negative regulation of cell killing (GO:0031342) | 4.32592234 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.32592234 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27110619 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.24090606 |
| 28 | response to host immune response (GO:0052572) | 4.24090606 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.23880353 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 4.23698111 |
| 31 | leukocyte aggregation (GO:0070486) | 4.16885724 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.15803629 |
| 33 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.11332106 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 4.09825420 |
| 35 | cellular extravasation (GO:0045123) | 4.02443417 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.95837873 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.94973676 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.89266155 |
| 39 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.87210789 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.86285904 |
| 41 | regulation of chemokine biosynthetic process (GO:0045073) | 3.85611518 |
| 42 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.81491899 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.74958328 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72103818 |
| 45 | leukocyte mediated cytotoxicity (GO:0001909) | 3.71426859 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71077979 |
| 47 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70598052 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.70347802 |
| 49 | response to host (GO:0075136) | 3.70347802 |
| 50 | response to host defenses (GO:0052200) | 3.70347802 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.69327226 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.64204999 |
| 53 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.63478475 |
| 54 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.59197725 |
| 55 | cellular response to zinc ion (GO:0071294) | 3.58543389 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.56476705 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52544755 |
| 58 | B cell mediated immunity (GO:0019724) | 3.52000393 |
| 59 | detection of biotic stimulus (GO:0009595) | 3.49502233 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.48443959 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.48443959 |
| 62 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.47542152 |
| 63 | microglial cell activation (GO:0001774) | 3.45249139 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.44244242 |
| 65 | response to type I interferon (GO:0034340) | 3.42954677 |
| 66 | positive regulation of leukocyte degranulation (GO:0043302) | 3.42674590 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.42453149 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.42163993 |
| 69 | defense response to protozoan (GO:0042832) | 3.41309361 |
| 70 | T-helper 1 type immune response (GO:0042088) | 3.41156588 |
| 71 | T cell migration (GO:0072678) | 3.40886680 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.36487892 |
| 73 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.35762677 |
| 74 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.35397060 |
| 75 | natural killer cell mediated immunity (GO:0002228) | 3.35397060 |
| 76 | cellular response to exogenous dsRNA (GO:0071360) | 3.35083279 |
| 77 | detection of other organism (GO:0098543) | 3.34738392 |
| 78 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32551790 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.29898094 |
| 80 | lymphocyte chemotaxis (GO:0048247) | 3.29458573 |
| 81 | phagosome maturation (GO:0090382) | 3.28564568 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27831134 |
| 83 | macrophage activation (GO:0042116) | 3.27786380 |
| 84 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.25821392 |
| 85 | negative regulation of mast cell activation (GO:0033004) | 3.22643807 |
| 86 | cellular response to interferon-alpha (GO:0035457) | 3.20263689 |
| 87 | regulation of monocyte chemotaxis (GO:0090025) | 3.19588231 |
| 88 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.17239200 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16554591 |
| 90 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14790411 |
| 91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.14242678 |
| 92 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.13617820 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 3.12002985 |
| 94 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11771572 |
| 95 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10672510 |
| 96 | positive regulation of interferon-beta production (GO:0032728) | 3.09652822 |
| 97 | neutrophil chemotaxis (GO:0030593) | 3.08813912 |
| 98 | mast cell activation (GO:0045576) | 3.07626575 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 3.06737449 |
| 100 | cellular response to interferon-beta (GO:0035458) | 3.06545125 |
| 101 | myeloid leukocyte activation (GO:0002274) | 3.05718509 |
| 102 | negative regulation of growth of symbiont in host (GO:0044130) | 3.05541268 |
| 103 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.05541268 |
| 104 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.05541268 |
| 105 | regulation of growth of symbiont in host (GO:0044126) | 3.05541268 |
| 106 | regulation of B cell differentiation (GO:0045577) | 3.05476740 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 3.05280301 |
| 108 | activated T cell proliferation (GO:0050798) | 3.04487298 |
| 109 | response to interferon-alpha (GO:0035455) | 3.04484355 |
| 110 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.04390253 |
| 111 | regulation of hypersensitivity (GO:0002883) | 3.04366412 |
| 112 | leukocyte degranulation (GO:0043299) | 3.04167388 |
| 113 | positive regulation of type 2 immune response (GO:0002830) | 3.03852249 |
| 114 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.03841112 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02572880 |
| 116 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.02572646 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.01859176 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00951351 |
| 119 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.00701740 |
| 120 | neutrophil migration (GO:1990266) | 3.00147429 |
| 121 | response to protozoan (GO:0001562) | 2.99997747 |
| 122 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.99531104 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.98042980 |
| 124 | detection of bacterium (GO:0016045) | 2.97778888 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.95771797 |
| 126 | negative regulation of interleukin-17 production (GO:0032700) | 2.94146741 |
| 127 | regulation of interleukin-17 production (GO:0032660) | 2.93862794 |
| 128 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.93106649 |
| 129 | positive regulation of heat generation (GO:0031652) | 2.92909619 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92818100 |
| 131 | cytokine secretion (GO:0050663) | 2.92406995 |
| 132 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89775509 |
| 133 | interferon-gamma production (GO:0032609) | 2.88799952 |
| 134 | positive regulation of interleukin-17 production (GO:0032740) | 2.86660235 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85886899 |
| 136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85518109 |
| 137 | regulation of interleukin-12 production (GO:0032655) | 2.84640919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.59054377 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.78226476 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.51072084 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.73921751 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.32791817 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.30726986 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.18335823 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.93983104 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.80770362 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68853974 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.62110545 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25401360 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.04980293 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02046940 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89030505 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84088866 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.72240873 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.69420699 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.43913488 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37061963 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32819184 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04547936 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.04051241 |
| 24 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.94005706 |
| 25 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.89714188 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84219166 |
| 27 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83912872 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80611559 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.79650597 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.73202592 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71795758 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66261965 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62117422 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60254859 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57531514 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55312858 |
| 37 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54838288 |
| 38 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54551121 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53361410 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48576850 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48001960 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47360421 |
| 43 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46984006 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45452761 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39489204 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38556126 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36906372 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.35556136 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35360386 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32466329 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31382565 |
| 52 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29221603 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.28858632 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27594169 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24936270 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23225372 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22507647 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21057404 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16344414 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15907804 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13211704 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12783297 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11149217 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04768031 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04024005 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03426780 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02486926 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01293265 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00041450 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99730062 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97213372 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96341645 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95108089 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90547055 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89637970 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89560034 |
| 77 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85760257 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.82628305 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82133746 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81848134 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80055512 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79896722 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79896722 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79058165 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78301102 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78256627 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77969969 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75966359 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75902046 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74775595 |
| 91 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74315119 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74244047 |
| 93 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74220380 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73484853 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73378626 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73252239 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72997038 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.72880448 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72867629 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.72561787 |
| 101 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72502978 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72501293 |
| 103 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.72342893 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72260116 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.71879635 |
| 106 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.69256588 |
| 107 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.69113749 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67893253 |
| 109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.66726072 |
| 110 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64888272 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64738323 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.62973482 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62672392 |
| 114 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62535359 |
| 115 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.61632669 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.60080237 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.59894262 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.59801299 |
| 119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.59533760 |
| 120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.59533760 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.59283277 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.58962603 |
| 123 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58460379 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.57800282 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.57033805 |
| 126 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.56644656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.09172207 |
| 2 | MP0003436_decreased_susceptibility_to | 4.37166919 |
| 3 | MP0009785_altered_susceptibility_to | 4.25534898 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 4.01302799 |
| 5 | MP0002419_abnormal_innate_immunity | 3.56047373 |
| 6 | MP0003303_peritoneal_inflammation | 3.48836018 |
| 7 | MP0005025_abnormal_response_to | 3.29391312 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.24203482 |
| 9 | MP0006082_CNS_inflammation | 3.11202114 |
| 10 | MP0004510_myositis | 3.10494440 |
| 11 | MP0003724_increased_susceptibility_to | 2.98595977 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.74702747 |
| 13 | MP0001790_abnormal_immune_system | 2.73979084 |
| 14 | MP0005387_immune_system_phenotype | 2.73979084 |
| 15 | MP0005671_abnormal_response_to | 2.60448428 |
| 16 | MP0002723_abnormal_immune_serum | 2.53404958 |
| 17 | MP0001800_abnormal_humoral_immune | 2.48039852 |
| 18 | MP0000685_abnormal_immune_system | 2.44310551 |
| 19 | MP0001819_abnormal_immune_cell | 2.34065387 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.29485128 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.28577299 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.28182615 |
| 23 | MP0009764_decreased_sensitivity_to | 2.25921990 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.18088188 |
| 25 | MP0001853_heart_inflammation | 2.10896885 |
| 26 | MP0001845_abnormal_inflammatory_respons | 1.99292162 |
| 27 | MP0000343_altered_response_to | 1.94991562 |
| 28 | MP0003075_altered_response_to | 1.93072001 |
| 29 | MP0002405_respiratory_system_inflammati | 1.92220901 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.84050623 |
| 31 | MP0003448_altered_tumor_morphology | 1.73480599 |
| 32 | MP0002006_tumorigenesis | 1.73001424 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.69525590 |
| 34 | MP0008469_abnormal_protein_level | 1.69160430 |
| 35 | MP0004947_skin_inflammation | 1.67108754 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.64012624 |
| 37 | MP0000858_altered_metastatic_potential | 1.59345242 |
| 38 | MP0000716_abnormal_immune_system | 1.58274067 |
| 39 | MP0009278_abnormal_bone_marrow | 1.55058970 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.49057321 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.48197369 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.48001143 |
| 43 | MP0005310_abnormal_salivary_gland | 1.47677396 |
| 44 | MP0002398_abnormal_bone_marrow | 1.44869487 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.44158111 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.42982349 |
| 47 | MP0005166_decreased_susceptibility_to | 1.40478991 |
| 48 | MP0003186_abnormal_redox_activity | 1.31244649 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.27877789 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.26372530 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.26372530 |
| 52 | MP0003195_calcinosis | 1.25195725 |
| 53 | MP0005164_abnormal_response_to | 1.25067914 |
| 54 | MP0002429_abnormal_blood_cell | 1.24584198 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.24152709 |
| 56 | MP0002132_abnormal_respiratory_system | 1.19937919 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.18122181 |
| 58 | MP0004858_abnormal_nervous_system | 1.10287966 |
| 59 | MP0003690_abnormal_glial_cell | 1.10077883 |
| 60 | MP0008004_abnormal_stomach_pH | 1.09707140 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.09455859 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.09410604 |
| 63 | MP0002722_abnormal_immune_system | 1.05470260 |
| 64 | MP0003828_pulmonary_edema | 1.04891608 |
| 65 | MP0000604_amyloidosis | 1.04879095 |
| 66 | MP0001851_eye_inflammation | 1.04472067 |
| 67 | MP0008260_abnormal_autophagy | 1.03398943 |
| 68 | MP0005390_skeleton_phenotype | 1.01963622 |
| 69 | MP0009763_increased_sensitivity_to | 1.01791104 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.00966645 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.99136297 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.94534532 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.91227345 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.90946300 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.90534145 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.87163507 |
| 77 | MP0010307_abnormal_tumor_latency | 0.82301761 |
| 78 | MP0000490_abnormal_crypts_of | 0.79841436 |
| 79 | MP0003300_gastrointestinal_ulcer | 0.78973822 |
| 80 | MP0005451_abnormal_body_composition | 0.77773151 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.77656760 |
| 82 | MP0000371_diluted_coat_color | 0.77368312 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 0.76682053 |
| 84 | MP0002933_joint_inflammation | 0.74596690 |
| 85 | MP0003045_fibrosis | 0.73095089 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.71751068 |
| 87 | MP0006054_spinal_hemorrhage | 0.70708000 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.69945457 |
| 89 | MP0003795_abnormal_bone_structure | 0.69174214 |
| 90 | MP0000920_abnormal_myelination | 0.67460645 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.65891432 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.65410923 |
| 93 | MP0004883_abnormal_blood_vessel | 0.65260696 |
| 94 | MP0000249_abnormal_blood_vessel | 0.65250069 |
| 95 | MP0005535_abnormal_body_temperature | 0.63653648 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.63317337 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.61278465 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.59281307 |
| 99 | MP0003866_abnormal_defecation | 0.58575549 |
| 100 | MP0003646_muscle_fatigue | 0.57757236 |
| 101 | MP0001764_abnormal_homeostasis | 0.55753620 |
| 102 | MP0004381_abnormal_hair_follicle | 0.54496526 |
| 103 | MP0003787_abnormal_imprinting | 0.53722650 |
| 104 | MP0001663_abnormal_digestive_system | 0.53083815 |
| 105 | MP0008873_increased_physiological_sensi | 0.52668160 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.52284876 |
| 107 | MP0009840_abnormal_foam_cell | 0.52265789 |
| 108 | MP0004484_altered_response_of | 0.52002783 |
| 109 | MP0003136_yellow_coat_color | 0.51346825 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.49245118 |
| 111 | MP0002254_reproductive_system_inflammat | 0.48745731 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.48703254 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.47734517 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.47506900 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.45772920 |
| 116 | MP0001873_stomach_inflammation | 0.44707298 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.44525556 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.42756443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.61147863 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.09417031 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.95765695 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.13865739 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.66499206 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.45777376 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 4.94240777 |
| 8 | Obstructive lung disease (HP:0006536) | 4.94240777 |
| 9 | Gingivitis (HP:0000230) | 4.75226619 |
| 10 | Recurrent skin infections (HP:0001581) | 4.73588301 |
| 11 | Myositis (HP:0100614) | 4.72480376 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54328602 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.51094071 |
| 14 | Orchitis (HP:0100796) | 4.41373386 |
| 15 | Stomatitis (HP:0010280) | 4.09117298 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.06310077 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.92578678 |
| 18 | Optic neuritis (HP:0100653) | 3.92578678 |
| 19 | Vasculitis (HP:0002633) | 3.67862894 |
| 20 | Periodontitis (HP:0000704) | 3.64447229 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.60056158 |
| 22 | Prostate neoplasm (HP:0100787) | 3.50647948 |
| 23 | Cellulitis (HP:0100658) | 3.49666894 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.33702683 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.32162003 |
| 26 | Urticaria (HP:0001025) | 3.32035985 |
| 27 | Recurrent viral infections (HP:0004429) | 3.31116366 |
| 28 | Increased IgM level (HP:0003496) | 3.30250544 |
| 29 | Pustule (HP:0200039) | 3.29637773 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29062758 |
| 31 | Meningitis (HP:0001287) | 3.18806753 |
| 32 | Thick nail (HP:0001805) | 3.11291086 |
| 33 | Basal ganglia calcification (HP:0002135) | 3.09933525 |
| 34 | Disinhibition (HP:0000734) | 3.05330550 |
| 35 | T lymphocytopenia (HP:0005403) | 3.05201391 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02204583 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02204583 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.96886867 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.94273534 |
| 40 | Axonal loss (HP:0003447) | 2.90296018 |
| 41 | Episodic fever (HP:0001954) | 2.89905057 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.88632670 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.85881827 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84305805 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84305805 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84305805 |
| 47 | Keratitis (HP:0000491) | 2.72857106 |
| 48 | Pulmonary embolism (HP:0002204) | 2.69799157 |
| 49 | Recurrent pneumonia (HP:0006532) | 2.68709276 |
| 50 | Hemoptysis (HP:0002105) | 2.66549113 |
| 51 | Joint hemorrhage (HP:0005261) | 2.66304381 |
| 52 | Petechiae (HP:0000967) | 2.66132451 |
| 53 | Abnormality of the prostate (HP:0008775) | 2.64877000 |
| 54 | Leukocytosis (HP:0001974) | 2.59612987 |
| 55 | Osteomyelitis (HP:0002754) | 2.58622259 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.55944892 |
| 57 | Gingival bleeding (HP:0000225) | 2.55643283 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.52048983 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.50198394 |
| 60 | Polyneuropathy (HP:0001271) | 2.49932594 |
| 61 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.49054712 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.48812295 |
| 63 | Abnormality of T cells (HP:0002843) | 2.41343693 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.36642863 |
| 65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.36613811 |
| 66 | Agnosia (HP:0010524) | 2.34663926 |
| 67 | Vertigo (HP:0002321) | 2.34328431 |
| 68 | Premature loss of primary teeth (HP:0006323) | 2.29922793 |
| 69 | Arterial thrombosis (HP:0004420) | 2.29739234 |
| 70 | Tetraparesis (HP:0002273) | 2.29346017 |
| 71 | Increased IgE level (HP:0003212) | 2.28445652 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.28357052 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.27279243 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.27279243 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.26952778 |
| 76 | Sepsis (HP:0100806) | 2.26641337 |
| 77 | Poor head control (HP:0002421) | 2.26313394 |
| 78 | Abnormality of the pericardium (HP:0001697) | 2.20169276 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.18329388 |
| 80 | Peritonitis (HP:0002586) | 2.18108183 |
| 81 | Cheilitis (HP:0100825) | 2.17160274 |
| 82 | Increased serum ferritin (HP:0003281) | 2.16952866 |
| 83 | Hematochezia (HP:0002573) | 2.16179468 |
| 84 | Gangrene (HP:0100758) | 2.14758099 |
| 85 | Chronic otitis media (HP:0000389) | 2.13379100 |
| 86 | Myocardial infarction (HP:0001658) | 2.12571426 |
| 87 | Amaurosis fugax (HP:0100576) | 2.11806170 |
| 88 | Stomach cancer (HP:0012126) | 2.10530646 |
| 89 | Skin ulcer (HP:0200042) | 2.07035267 |
| 90 | Eosinophilia (HP:0001880) | 2.05622869 |
| 91 | Bone pain (HP:0002653) | 2.04540655 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.04297193 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03770949 |
| 94 | Epistaxis (HP:0000421) | 2.03496935 |
| 95 | Glomerulonephritis (HP:0000099) | 1.99518881 |
| 96 | Abnormality of B cell number (HP:0010975) | 1.98558743 |
| 97 | Dysostosis multiplex (HP:0000943) | 1.97687453 |
| 98 | Thrombophlebitis (HP:0004418) | 1.96908710 |
| 99 | Albinism (HP:0001022) | 1.96217056 |
| 100 | Purpura (HP:0000979) | 1.95398087 |
| 101 | Chest pain (HP:0100749) | 1.95246765 |
| 102 | Neoplasm of head and neck (HP:0012288) | 1.92166185 |
| 103 | Esophageal neoplasm (HP:0100751) | 1.92166185 |
| 104 | Abnormality of the endocardium (HP:0004306) | 1.92096817 |
| 105 | Lower limb hyperreflexia (HP:0002395) | 1.91659411 |
| 106 | Arthralgia (HP:0002829) | 1.90752714 |
| 107 | Autoimmune hemolytic anemia (HP:0001890) | 1.90105859 |
| 108 | Constricted visual fields (HP:0001133) | 1.88119889 |
| 109 | Amyloidosis (HP:0011034) | 1.88066882 |
| 110 | Anorexia (HP:0002039) | 1.87814786 |
| 111 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87211430 |
| 112 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86557010 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86068176 |
| 114 | Nephritis (HP:0000123) | 1.85121696 |
| 115 | Hypochromic anemia (HP:0001931) | 1.82494267 |
| 116 | Acne (HP:0001061) | 1.82248256 |
| 117 | Mutism (HP:0002300) | 1.81805227 |
| 118 | Glomerulopathy (HP:0100820) | 1.81653719 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.80633381 |
| 120 | Loss of speech (HP:0002371) | 1.79697999 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 1.79123895 |
| 122 | Abnormality of T cell number (HP:0011839) | 1.78141089 |
| 123 | Acute hepatic failure (HP:0006554) | 1.76784017 |
| 124 | Prolonged bleeding time (HP:0003010) | 1.75171111 |
| 125 | Encephalitis (HP:0002383) | 1.74723501 |
| 126 | Joint swelling (HP:0001386) | 1.72846599 |
| 127 | Microcytic anemia (HP:0001935) | 1.72746676 |
| 128 | Granulocytopenia (HP:0001913) | 1.71207585 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.70241692 |
| 130 | Abnormality of eosinophils (HP:0001879) | 1.70039082 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.68744647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.35724751 |
| 2 | MAP3K14 | 4.23117238 |
| 3 | IRAK4 | 4.02777922 |
| 4 | BLK | 3.31066202 |
| 5 | PBK | 3.23512759 |
| 6 | TBK1 | 2.87450980 |
| 7 | TYK2 | 2.73688570 |
| 8 | MAP4K1 | 2.67428809 |
| 9 | IRAK3 | 2.63163735 |
| 10 | ERN1 | 2.34524710 |
| 11 | TXK | 2.28487072 |
| 12 | IKBKB | 2.20970969 |
| 13 | MAP3K12 | 2.04978902 |
| 14 | IKBKE | 2.04145623 |
| 15 | KIT | 2.03327099 |
| 16 | NEK9 | 2.02200730 |
| 17 | PIM2 | 2.00318761 |
| 18 | JAK3 | 1.99606611 |
| 19 | TNK2 | 1.96323198 |
| 20 | MAP3K13 | 1.90310167 |
| 21 | CSK | 1.85444423 |
| 22 | JAK1 | 1.82156242 |
| 23 | FGR | 1.62585687 |
| 24 | FRK | 1.62356896 |
| 25 | SYK | 1.57906248 |
| 26 | MST4 | 1.54617644 |
| 27 | BTK | 1.50796507 |
| 28 | MAP4K2 | 1.50590177 |
| 29 | TEC | 1.49388165 |
| 30 | LYN | 1.43179882 |
| 31 | MATK | 1.40267245 |
| 32 | HCK | 1.36929005 |
| 33 | TAOK3 | 1.36266300 |
| 34 | BMPR2 | 1.34500664 |
| 35 | MAP3K6 | 1.33672564 |
| 36 | ZAP70 | 1.32344543 |
| 37 | CSF1R | 1.23943358 |
| 38 | ARAF | 1.20791243 |
| 39 | FES | 1.16879937 |
| 40 | CDK19 | 1.16839804 |
| 41 | DAPK2 | 1.12466670 |
| 42 | CHUK | 1.11988640 |
| 43 | ABL2 | 1.11784253 |
| 44 | JAK2 | 1.09362992 |
| 45 | CLK1 | 1.07786715 |
| 46 | PIM1 | 1.07468755 |
| 47 | BMX | 1.07302565 |
| 48 | YES1 | 1.06382833 |
| 49 | MST1R | 1.04827418 |
| 50 | MAP3K3 | 1.02801017 |
| 51 | EIF2AK2 | 1.01469059 |
| 52 | LCK | 0.98902185 |
| 53 | STK4 | 0.98019143 |
| 54 | RPS6KA4 | 0.97551742 |
| 55 | TRPM7 | 0.96834591 |
| 56 | TAOK1 | 0.96819940 |
| 57 | ACVR1B | 0.92831622 |
| 58 | TLK1 | 0.91907110 |
| 59 | MAP3K10 | 0.91843691 |
| 60 | EPHB1 | 0.90870172 |
| 61 | MAP2K4 | 0.90024896 |
| 62 | ERBB3 | 0.84189468 |
| 63 | NME2 | 0.79899197 |
| 64 | PRKCD | 0.78581263 |
| 65 | MARK3 | 0.78458717 |
| 66 | PTK2B | 0.78181201 |
| 67 | TAOK2 | 0.74634094 |
| 68 | NUAK1 | 0.73488861 |
| 69 | STK10 | 0.72921215 |
| 70 | MAP2K6 | 0.71928308 |
| 71 | MAP3K5 | 0.66132663 |
| 72 | FGFR3 | 0.65865622 |
| 73 | ITK | 0.65468938 |
| 74 | OXSR1 | 0.65141323 |
| 75 | PRPF4B | 0.64836976 |
| 76 | PINK1 | 0.64646746 |
| 77 | SIK2 | 0.64480642 |
| 78 | IRAK2 | 0.63090428 |
| 79 | ABL1 | 0.61230892 |
| 80 | IRAK1 | 0.60488455 |
| 81 | RIPK1 | 0.59625175 |
| 82 | PRKCQ | 0.59601737 |
| 83 | GRK7 | 0.56499366 |
| 84 | HIPK2 | 0.56245989 |
| 85 | MAP2K3 | 0.55353489 |
| 86 | STK24 | 0.53277043 |
| 87 | PAK4 | 0.51786033 |
| 88 | TGFBR2 | 0.51438474 |
| 89 | PIK3CG | 0.49644203 |
| 90 | EGFR | 0.47991363 |
| 91 | FLT3 | 0.45926989 |
| 92 | DYRK3 | 0.45655734 |
| 93 | ADRBK1 | 0.44115703 |
| 94 | LRRK2 | 0.43864093 |
| 95 | WNK1 | 0.43769948 |
| 96 | PDK1 | 0.42867135 |
| 97 | RPS6KA6 | 0.40757654 |
| 98 | PDPK1 | 0.40040745 |
| 99 | MYLK | 0.39138256 |
| 100 | DAPK3 | 0.37055120 |
| 101 | EIF2AK1 | 0.37049505 |
| 102 | FYN | 0.36004305 |
| 103 | SGK2 | 0.35277845 |
| 104 | STK11 | 0.33914807 |
| 105 | CDK6 | 0.33783528 |
| 106 | TESK2 | 0.32806729 |
| 107 | CAMKK2 | 0.32720180 |
| 108 | GRK6 | 0.32427339 |
| 109 | MAPKAPK2 | 0.32062802 |
| 110 | STK3 | 0.32010348 |
| 111 | NLK | 0.31830761 |
| 112 | FGFR4 | 0.30625228 |
| 113 | MARK2 | 0.30582395 |
| 114 | RPS6KL1 | 0.29717576 |
| 115 | RPS6KC1 | 0.29717576 |
| 116 | MAPK7 | 0.28836353 |
| 117 | SIK3 | 0.28660209 |
| 118 | MOS | 0.28222068 |
| 119 | EIF2AK3 | 0.27650552 |
| 120 | WNK3 | 0.27377874 |
| 121 | ADRBK2 | 0.27137754 |
| 122 | CAMK4 | 0.25219043 |
| 123 | CAMK1D | 0.25007213 |
| 124 | SGK3 | 0.24487671 |
| 125 | DAPK1 | 0.24381938 |
| 126 | GRK1 | 0.24346118 |
| 127 | MAP3K11 | 0.23614167 |
| 128 | MAP3K1 | 0.23475623 |
| 129 | TESK1 | 0.22692201 |
| 130 | TTN | 0.22541117 |
| 131 | EPHA3 | 0.21802583 |
| 132 | IGF1R | 0.21578238 |
| 133 | RAF1 | 0.20959151 |
| 134 | ILK | 0.19188387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.65722260 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.36648400 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.10842422 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.77736565 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74419115 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.72196470 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.64837032 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.52837602 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48709628 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45880696 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.35371172 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.31799037 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.24043187 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.21758584 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.17950461 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.12441033 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 2.04877247 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02872105 |
| 19 | Measles_Homo sapiens_hsa05162 | 2.02568324 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 2.01227985 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92665657 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.89759157 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.89260907 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.83610914 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81621829 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73183648 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62246088 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58494741 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53573125 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52730410 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45030945 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45000504 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40475583 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.40335981 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39719088 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39162363 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.36903582 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21111017 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18221713 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12405117 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09591966 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09093875 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08789605 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04330103 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.01963047 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01257966 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95184785 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93325075 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.90581986 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90321888 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.90289763 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87154674 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85608982 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84281833 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83510321 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82080781 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81897348 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.80550782 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77481006 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68583151 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66830988 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65168602 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60933179 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59673212 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59572552 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57891398 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57576318 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54627187 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51697338 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51479479 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48257024 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47112635 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46734369 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.46045266 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42484801 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40629135 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40361227 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40037627 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39984061 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39961207 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37186516 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.37034460 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36943225 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36597650 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34285403 |
| 86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33780929 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33738214 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33146167 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32848294 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32385508 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31906166 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31893421 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.30712975 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30486622 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30297696 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27210648 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.26413257 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24896362 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20586692 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18988982 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18891128 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16496088 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14255437 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13743994 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.13707645 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13365213 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13242095 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12440260 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12102008 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11169270 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.10215081 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.09610429 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09250190 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.08540392 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08426411 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07831959 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.07118531 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.06206454 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.05436774 |

